Drawing for NEW ENGLAND BIOLABS INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE

USPTO serial 87854070

NEW ENGLAND BIOLABS INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE

Reviewed by CopyMark Law Group

Reg. 5743088Status 710
Filing date
Status date
Registration date
May 7, 2019
Examiner
ROSSMAN, WILLIAM M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NEW ENGLAND BIOLABS INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Harriet M. Strimpel, D.Phil.

HARRIET M. STRIMPEL, D.PHIL. NEW ENGLAND BIOLABS, INC.240 COUNTY ROADIPSWICH, MA 01938UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprised of enzymes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for diagnostic applications and devices for scientific use; Enzymes and kits comprised of enzymes for diagnostic applications and devices for scientific use; Reagents and kits comprised of enzymes for replication and amplification of DNA for scientific research purposes; Reagents and kits comprised of enzymes for scientific use in sequencing nucleic acids; Reagents and kits comprised of enzymes for scientific research, namely, genetic research, clinical or medical laboratory use; Reagents and kits comprised of enzymes for reverse transcribing RNA into DNA for scientific research purposes; Nucleic acid binding reagents for scientific research purposes; Reagents and kits comprised of enzymes for DNA cleavage and ligation for scientific research purposes; Reagents and kits comprised of enzymes for cloning for scientific research purposes; Reagents and kits comprised of enzymes for assembly of nucleic acid fragments; Cells for use in molecular biology; Kits comprised of enzyme buffers, polymerase, nucleotides, DNA matrices, beads, enzymes and/or primers for scientific and research use and for diagnostic use; Protein arrays and nucleotide arrays for scientific and medical research; Reagents for size standard markers with premixed loading dye for use in molecular biology for scientific research; Reagents, namely, Ribonucleases, double-stranded RNA, RNA polymerases, DNA vectors, DNA plasmids, ribonucleotide triphosphates for the synthesis and cleavage of double-stranded RNA for laboratory and research use; Reagents, namely, DNA adapters, DNA and RNA polymerases, DNA and RNA ligases, DNA and RNA molecular weight markers and DNA cloning vectors for the cloning of double-stranded RNA for laboratory and research use; Reagents for transfer of double-stranded RNA to cells for laboratory and scientific research use; Genome editing reagents and polynucleotide assembly reagents for scientific and research use; Biological compounds for synthesis and repair of polynucleotides, namely, proteins, peptides, polypeptides, DNA, DNA binding proteins, and enzymes; Laboratory research kits for synthesis and repair of polynucleotides, consisting primarily of enzymes, binding proteins and other proteins, nucleic acids, probes, buffers, and associated reagents, all for use in basic research, diagnostics and pharmaceutical developmentSECTION 8 - CANCELLEDNov 1, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2025C8..CANCELLED SEC. 8 (6-YR)—
May 7, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 4, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 7, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 18, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 17, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 17, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2018DOCKASSIGNED TO EXAMINER—
Apr 7, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 5, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 31, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance